Therapeutic Options for Low Dose Proleukin in Autoimmune Liver Diseases through Selective Induction of Phospho-STAT5, Regulatory Phenotype and Prosurvival BCL-2 in TREG
2016
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI